Heme oxygenase-1 mediated memorial and revivable protective effect of ischemic preconditioning on brain injury

CNS Neuroscience and Therapeutics

Volumn 19, Issue 12, 2013, Pages 963-968

  Le, Li Li ^a   Li, Xue Yi ^a   Meng, Dan ^a   Liang, Qiu Jun ^a   Wang, Xin Hong ^a   Li, Ning ^a   Quan, Jing ^a   Xiang, Meng ^a   Jiang, Mei ^b   Sun, Jian ^b   Chen, Si Feng ^a  

^a FUDAN UNIVERSITY   (China)

^b Gongli Hospital   (China)

Author keywords

Adenosine receptor; Heme oxygenase 1; Ischemic preconditioning; Stroke

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; HEMIN; PROTOPORPHYRIN IX ZINC; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BLOOD FLOW; BRAIN INFARCTION; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTERNAL CAROTID ARTERY; ISCHEMIC PRECONDITIONING; MALE; MIDDLE CEREBRAL ARTERY; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; STROKE PATIENT; WESTERN BLOTTING;

ADENOSINE RECEPTOR; HEME OXYGENASE-1; ISCHEMIC PRECONDITIONING; STROKE;

ANIMALS; BRAIN INFARCTION; BRAIN INJURIES; ENZYME INHIBITORS; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; ISCHEMIC PRECONDITIONING; MALE; MEMORY DISORDERS; NERVOUS SYSTEM DISEASES; PROTOPORPHYRINS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1;

EID: 84888202324     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12152     Document Type: Article

References (25)

1. Donnan GA, Davis SM. Stroke: Expanded indications for stroke thrombolysis-what next? Nat Rev Neurol 2012;8:482-483.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation 2013;127:e6-e245.
3. Liu XQ, Sheng R, Qin ZH. The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacol Sin 2009;30:1071-1080.
4. Wegener S, Gottschalk B, Jovanovic V, et al. Transient ischemic attacks before ischemic stroke: Preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 2004;35:616-621.
5. Steiger HJ, Hanggi D. Ischaemic preconditioning of the brain, mechanisms and applications. Acta Neurochir (Wien) 2007;149:1-10.
6. Zeynalov E, Shah ZA, Li RC, Dore S. Heme oxygenase 1 is associated with ischemic preconditioning-induced protection against brain ischemia. Neurobiol Dis 2009;35:264-269.
7. Bigdeli MR. Neuroprotection caused by hyperoxia preconditioning in animal stroke models. Sci World J 2011;11:403-421.
8. Akamatsu Y, Haga M, Tyagi S, et al. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J 2004;18:771-772.
9. Basireddy M, Lindsay JT, Agarwal A, Balkovetz DF. Epithelial cell polarity and hypoxia influence heme oxygenase-1 expression by heme in renal epithelial cells. Am J Physiol Renal Physiol 2006;291:F790-F795.
10. Chen S, Kapturczak MH, Wasserfall C, et al. Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc Natl Acad Sci U S A 2005;102:7251-7256.
11. Eckle T, Hartmann K, Bonney S, et al. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med 2012;18:774-782.
12. Williams-Pritchard G, Knight M, Hoe LS, Headrick JP, Peart JN. Essential role of EGFR in cardioprotection and signaling responses to A1 adenosine receptors and ischemic preconditioning. Am J Physiol Heart Circ Physiol 2011;300:H2161-H2168.
13. Hu S, Dong H, Zhang H, et al. Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats. Brain Res 2012;1459:81-90.
14. Gomes CV, Kaster MP, Tome AR, Agostinho PM, Cunha RA. Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration. Biochim Biophys Acta 2011;1808:1380-1399.
15. Stone TW. Adenosine, neurodegeneration and neuroprotection. Neurol Res 2005;27:161-168.
16. Trincavelli ML, Melani A, Guidi S, et al. Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain. J Neurochem 2008;104:479-490.
17. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91.
18. Kelly S, Bliss TM, Shah AK, et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A 2004;101:11839-11844.
19. Barbagallo I, Galvano F, Frigiola A, et al. Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases. Antioxid Redox Signal 2013;18:507-521.
20. Ferrandiz ML, Devesa I. Inducers of heme oxygenase-1. Curr Pharm Des 2008;14:473-486.
21. Li C, Hossieny P, Wu BJ, Qawasmeh A, Beck K, Stocker R. Pharmacologic induction of heme oxygenase-1. Antioxid Redox Signal 2007;9:2227-2239.
22. Wu ML, Ho YC, Yet SF. A central role of heme oxygenase-1 in cardiovascular protection. Antioxid Redox Signal 2011;15:1835-1846.
23. Deshane J, Chen S, Caballero S, et al. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 2007;204:605-618.
24. Fredholm BB. Adenosine and neuroprotection. Int Rev Neurobiol 1997;40:259-280.
25. Li B, Roth S. Retinal ischemic preconditioning in the rat: Requirement for adenosine and repetitive induction. Invest Ophthalmol Vis Sci 1999;40:1200-1216.